Beam Therapeutics BEAM Q2 2025 earnings
Reported August 5, 2025 · Before market open
Revenue$8.5MMiss by $3.1M
EPS-$1.00Beat by $0.04
Revenue estimate$11.5M
EPS estimate-$1.04
Next report
Aug 4, 2026 (In 6 days)Revenue estimate$16.4M
EPS estimate-$1.11
Financials
Q2 2025Valuation & ratios
Versus estimates
Revenue
Diluted EPS
Ask the moment Beam Therapeutics reports.
Connect your AI and ask the moment the filing drops. It reads the release, surfaces what management said, and gives you its own read.
Connect your AI
Claude
Questions, answered.
- When did Beam Therapeutics report Q2 2025 earnings?
- Beam Therapeutics (BEAM) reported Q2 2025 earnings on August 5, 2025 before market open.
- What were Beam Therapeutics's Q2 2025 revenue and EPS?
- Beam Therapeutics reported revenue of $8.5M and eps of $-1.00 for Q2 2025.
- Did Beam Therapeutics beat estimates in Q2 2025?
- Revenue missed the consensus estimate of $11.5M by $3.1M. EPS beat the consensus estimate of $-1.04 by $0.04.
- How did Beam Therapeutics's Q2 2025 results compare year-over-year?
- Compared to the same quarter a year prior, revenue declined 28.1% from $11.8M a year earlier and eps grew 9.9% from $-1.11.
- Where can I find Beam Therapeutics's Q2 2025 SEC filings?
- You can read the 10-Q periodic report (0000950170-25-102393) directly on SEC EDGAR. The filing index links above go to sec.gov.